01
Responsibility
We act in the interest of patients, partners, and public health.
About Behphar
Built to keep healthcare moving.
Behphar Pharmaceutical Holding coordinates manufacturing, licensing, logistics, consumer health, biologics, and specialty therapeutics under one governance model, with a single purpose: reliable access to quality medicines.
Who We Are
More than a group of companies, a coordinated healthcare platform.
Behphar brings together specialized subsidiaries spanning the pharmaceutical value chain, from GMP-certified manufacturing and international licensing to nationwide distribution, consumer health, plasma-derived therapies, and specialty care.
Operating as one platform allows the group to align quality standards, share operational strength, and respond reliably to the needs of patients, healthcare professionals, and partners across Iran.
Meet the companies →
The Role of the Holding
Strategic governance at the center
Behphar is not only a commercial entity. It is a governance platform that gives every subsidiary direction, discipline, and support.
Strategic Oversight
Setting long-term direction, coordinating investment, and aligning the subsidiaries behind shared healthcare goals.
Risk Management
Identifying and managing operational, supply, and market risks so that essential therapies keep reaching patients.
Regulatory Alignment
Keeping every company aligned with national requirements and international standards across all activities.
Quality Direction
Defining group-wide quality policy and oversight, from manufacturing floors to the last step of distribution.
Our Mission
To ensure reliable access to essential healthcare products through an integrated, responsibly governed pharmaceutical ecosystem built on quality, accountability, and public trust.
Our Vision
To be a trusted healthcare holding that enhances national treatment capacity, supports high standards of safety, and contributes to long-term healthcare stability and improvement.
Core Values
What guides every decision
02
Quality
We hold every product and process to rigorous standards.
03
Integrity
We work transparently and keep our commitments.
04
Reliability
We deliver consistently, so healthcare never has to wait.
05
Stewardship
We manage resources and partnerships for the long term.
Milestones
The journey so far
Step by step, Behphar has grown into an integrated pharmaceutical ecosystem, with each company adding a defined capability to the group.
2001
Formation of Behestan Darou
The group gains its market-access and international licensing arm.
2005
Launch of Darousazi Behestan
Domestic GMP-certified manufacturing capability comes online.
2005
Establishment of Behestan Behdasht
The group enters consumer healthcare, wellness, and preventive care.
2005
Expansion of Behestan Pakhsh logistics network
Nationwide distribution and logistics become a defined pillar of the group.
2006
Establishment of Behestan Plasma
Plasma collection begins, supporting access to life-saving plasma-derived therapies.
2009
Formation of Behestan Plasma Alborz
The plasma network expands with additional capability for donor collection and biologic treatment support.
2010
Establishment of Behphar Holding
The holding is founded to bring strategic coordination to a growing family of pharmaceutical companies.
2015
Founding of Valean Darou
Specialty therapeutics join the platform, with a focus on ophthalmology and rare diseases.
Ongoing
Strategic portfolio expansion and modernization
Continued investment in capacity, technology transfer, and healthcare infrastructure.
Our Group
The companies behind the mission.
Six specialized subsidiaries, one coordinated healthcare platform.